Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Click here for more information

Click here to sign up for SAGE Journal Email Alerts today!

Sign In to gain access to subscriptions and/or personal tools.
Journal of Child Neurology
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Awaad, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Awaad, Y.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Tics in Tourette Syndrome: New Treatment Options

Yasser Awaad, MD, MSc

Children's Hospital of Michigan, Neurology Division, and the Movement Disorder Clinic, Wayne State University, School of Medicine, Detroit, MI, yawaad{at}med.wayne.edu

Tourette Syndrome is a familial neurobehavioral disorder characterized by fluctuating involuntary motor and/or vocal tics. The most commonly used medications to treat Tourette's syndrome are haloperidol, pimozide, fluphenazine, and clonidine, all of which may have considerable side effects. We enrolled 450 patients with tics/Tourette's syndrome to be treated with baclofen/botolinum toxin type A for their symptoms. Global severity of tic symptoms was rated by the Yale Global Tic Severity Scale and a quantified videotaped micro-structured analysis of tics. We found that baclofen/botolinum toxin type A are very effective, safe, and reliable in the treatment of tics/Tourette's syndrome. It is worthwhile considering this treatment approach in patients with tics/Tourette's syndrome in order to reduce or avoid the side effects of other medications. Further studies, however, are required. (J Child Neurol 1999 ; 14:316-319).

Journal of Child Neurology, Vol. 14, No. 5, 316-319 (1999)
DOI: 10.1177/088307389901400508
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
 J Child NeurolHome page
D. Gilbert
Treatment of Children and Adolescents With Tics and Tourette Syndrome
J Child Neurol, August 1, 2006; 21(8): 690 - 700.
[Abstract] [PDF]

Home page
 NeurologyHome page
H. S. Singer, J. Wendlandt, M. Krieger, and J. Giuliano
Baclofen treatment in Tourette syndrome: A double-blind, placebo-controlled, crossover trial
Neurology, March 13, 2001; 56(5): 599 - 604.
[Abstract] [Full Text] [PDF]

Home page
 J Child NeurolHome page
C. Kwak and J. Jankovic
Tics in Tourette Syndrome and Botulinum Toxin
J Child Neurol, September 1, 2000; 15(9): 631 - 632.
[PDF]